Bill > SF3155

This bill involves a significant appropriation and funding adjustment for Amyotrophic Lateral Sclerosis (ALS) research in Minnesota. Specifically, the bill cancels $15,000,000 from a previous appropriation and then creates a new $15,000,000 appropriation in fiscal year 2026 to be awarded to the University of Minnesota's Board of Regents for a collaborative research partnership with the Mayo Clinic focused on ALS research. The goal of this research is to improve the lives of individuals with ALS and work towards finding a cure for the disease. The appropriation is designated as a one-time funding and will not cancel until June 30, 2029. Additionally, the bill requires the Board of Regents to submit annual reports to the legislature from January 15, 2026, until January 15, 2030, detailing how the research funds have been utilized. The bill also repeals previous legislation related to ALS research appropriations, effectively replacing the earlier funding mechanism with this new collaborative research approach.

Education

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF3155&ssn=0&y=2025